Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06584630

Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Molecular classification that has been recently incorporated in FIGO classification of endometrial cancer is a new triage tool for the better management of endometrial cancer patients.

Conditions

Timeline

Start date
2022-01-01
Primary completion
2024-12-31
Completion
2025-12-31
First posted
2024-09-05
Last updated
2024-09-19

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT06584630. Inclusion in this directory is not an endorsement.

Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning. (NCT06584630) · Clinical Trials Directory